Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$3.99 - $6.04 $235,809 - $356,964
-59,100 Reduced 73.23%
21,600 $110,000
Q1 2024

May 07, 2024

BUY
$5.3 - $7.51 $261,820 - $370,994
49,400 Added 157.83%
80,700 $461,000
Q4 2023

Feb 14, 2024

BUY
$4.35 - $6.88 $63,074 - $99,760
14,500 Added 86.31%
31,300 $200,000
Q3 2023

Nov 14, 2023

BUY
$4.52 - $8.9 $75,936 - $149,520
16,800 New
16,800 $75,000
Q1 2023

May 16, 2023

BUY
$5.3 - $10.93 $118,720 - $244,832
22,400 New
22,400 $118,000
Q2 2022

Aug 15, 2022

BUY
$6.92 - $15.97 $87,192 - $201,222
12,600 New
12,600 $137,000

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $593M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.